WI
WealthCare Investment Partners, LLC
13F filer · CIK 0001908462Reported Aug 10, 2026
Net buyer this quarter
13F portfolio value$412MU.S. long equity reported on 13F
Positions719 new · 4 closed
Net flow last quarter+$8.48MBuys minus sells
Top 10 positions weight19.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 10, 202671 positions | |||||
| $33.1M | 8.04% | Not reported | +1.6% | Q4 2021 | |
| $15.4M | 3.74% | Not reported | +4.1% | Q4 2021 | |
| $8.45M | 2.05% | Not reported | +15.1% | Q1 2022 | |
| $7.14M | 1.73% | 0.01% | -9.7% | Q4 2021 | |
| $3.97M | 0.97% | 0.00% | +27.5% | Q4 2021 | |
| $3.07M | 0.74% | 0.00% | +13.4% | Q4 2021 | |
| $2.9M | 0.70% | 0.01% | +14.4% | Q4 2021 | |
| $2.79M | 0.68% | 0.00% | -3.7% | Q4 2021 | |
| $2.69M | 0.65% | 0.01% | +7.8% | Q4 2021 | |
| $2.08M | 0.51% | 0.29% | +70.4% | Q2 2025 | |
| $1.75M | 0.42% | 0.00% | -5.7% | Q3 2023 | |
| $1.47M | 0.36% | 0.00% | +10.2% | Q4 2021 | |
| $1.45M | 0.35% | 0.00% | +31.3% | Q2 2025 | |
| $1.42M | 0.34% | 0.00% | +6.2% | Q4 2021 | |
| $1.3M | 0.32% | 0.00% | +14.5% | Q3 2022 | |
| $1.21M | 0.29% | 0.00% | +8.7% | Q4 2024 | |
| $1.14M | 0.28% | Not reported | -0.6% | Q4 2023 | |
| $976K | 0.24% | 0.00% | +0.4% | Q4 2021 | |
| $955K | 0.23% | Not reported | -19.2% | Q1 2022 | |
| $895K | 0.22% | 0.00% | +56.1% | Q3 2025 | |
| $864K | 0.21% | 0.00% | +0.9% | Q4 2021 | |
| $752K | 0.18% | 0.00% | +1.1% | Q4 2021 | |
| $715K | 0.17% | Not reported | -0.9% | Q4 2021 | |
| $702K | 0.17% | 0.00% | +0.1% | Q3 2025 | |
| $641K | 0.16% | Not reported | +1.5% | Q1 2023 | |
| $572K | 0.14% | 0.01% | Not reported | Q4 2022 | |
| PBPMBSPuramed Bioscience Inc. | $519K | 0.13% | 0.01% | +34.0% | Q1 2026 |
| $518K | 0.13% | 0.00% | +0.5% | Q4 2021 | |
| $508K | 0.12% | 0.00% | +0.4% | Q3 2025 | |
| $501K | 0.12% | Not reported | -7.7% | Q4 2023 | |
| $496K | 0.12% | 0.00% | -44.6% | Q3 2025 | |
| $462K | 0.11% | Not reported | -5.6% | Q4 2021 | |
| $441K | 0.11% | 0.00% | -14.5% | Q4 2025 | |
| $435K | 0.11% | 0.00% | +16.5% | Q4 2024 | |
| $405K | 0.10% | 0.00% | +1.4% | Q1 2022 | |
| $397K | 0.10% | 0.00% | Not reported | Q3 2025 | |
| $397K | 0.10% | 0.00% | -18.9% | Q4 2021 | |
| $392K | 0.10% | 0.00% | +39.1% | Q3 2025 | |
| $387K | 0.09% | 0.00% | +0.4% | Q4 2021 | |
| $387K | 0.09% | Not reported | +30.2% | Q4 2023 | |
| $386K | 0.09% | 0.00% | New | Q2 2026 | |
| $374K | 0.09% | Not reported | +63.3% | Q3 2025 | |
| $366K | 0.09% | 0.00% | +5.1% | Q4 2021 | |
| $337K | 0.08% | 0.00% | Not reported | Q1 2026 | |
| $331K | 0.08% | 0.00% | +0.7% | Q4 2021 | |
| $318K | 0.08% | 0.00% | New | Q2 2026 | |
| $317K | 0.08% | 0.02% | +11.4% | Q4 2024 | |
| $316K | 0.08% | 0.00% | +0.3% | Q4 2024 | |
| $283K | 0.07% | 0.00% | +0.8% | Q2 2024 | |
| $282K | 0.07% | Not reported | -29.8% | Q1 2026 | |
| Q1 2026Reported Apr 9, 202666 positions | |||||
| $26M | 7.21% | Not reported | -0.7% | Q4 2021 | |
| $14.5M | 4.01% | Not reported | +1.4% | Q4 2021 | |
| $8.93M | 2.48% | 0.01% | -5.9% | Q4 2021 | |
| $6.76M | 1.88% | Not reported | -2.5% | Q1 2022 | |
| $3.05M | 0.85% | 0.01% | +1.5% | Q4 2021 | |
| $2.89M | 0.80% | 0.00% | +2.6% | Q4 2021 | |
| $2.72M | 0.76% | 0.00% | -0.4% | Q4 2021 | |
| $2.4M | 0.67% | 0.00% | +15.5% | Q4 2021 | |
| $2.13M | 0.59% | 0.00% | +17.3% | Q4 2021 | |
| $1.66M | 0.46% | 0.00% | +0.4% | Q3 2023 | |
| $1.32M | 0.37% | 0.00% | +9.1% | Q2 2025 | |
| $1.21M | 0.34% | 0.00% | +44.0% | Q4 2024 | |
| $1.15M | 0.32% | Not reported | -2.8% | Q4 2023 | |
| $1.09M | 0.30% | 0.00% | +0.3% | Q4 2021 | |
| $1.01M | 0.28% | 0.00% | -0.2% | Q3 2022 | |
| $999K | 0.28% | 0.00% | +6.3% | Q4 2021 | |
| $948K | 0.26% | 0.00% | +14.9% | Q1 2022 | |
| $931K | 0.26% | 0.00% | -0.9% | Q4 2021 | |
| $893K | 0.25% | 0.17% | +26.6% | Q2 2025 | |
| $888K | 0.25% | 0.00% | Not reported | Q4 2021 | |
| $752K | 0.21% | 0.04% | Not reported | Q4 2021 | |
| $719K | 0.20% | Not reported | Not reported | Q1 2022 | |
| $700K | 0.19% | 0.00% | +0.3% | Q4 2021 | |
| $681K | 0.19% | 0.00% | 0.0% | Q4 2021 | |
| $637K | 0.18% | 0.00% | Not reported | Q4 2021 | |
| $598K | 0.17% | Not reported | -1.4% | Q4 2021 | |
| $555K | 0.15% | Not reported | -1.5% | Q1 2023 | |
| $542K | 0.15% | 0.00% | -0.4% | Q3 2025 | |
| $511K | 0.14% | Not reported | -6.1% | Q4 2021 | |
| $489K | 0.14% | 0.00% | +0.3% | Q4 2021 | |
| $445K | 0.12% | Not reported | -3.0% | Q4 2023 | |
| $436K | 0.12% | 0.00% | New | Q1 2026 | |
| $417K | 0.12% | 0.00% | +100.2% | Q3 2025 | |
| $390K | 0.11% | 0.02% | +7.8% | Q4 2024 | |
| PBPMBSPuramed Bioscience Inc. | $389K | 0.11% | 0.00% | New | Q1 2026 |
| $373K | 0.10% | 0.00% | +25.1% | Q3 2025 | |
| $368K | 0.10% | 0.01% | +48.7% | Q4 2022 | |
| $365K | 0.10% | 0.00% | -0.1% | Q3 2025 | |
| $347K | 0.10% | 0.00% | +0.4% | Q4 2021 | |
| $344K | 0.10% | 0.00% | Not reported | Q1 2022 | |
| $327K | 0.09% | 0.00% | New | Q1 2026 | |
| $327K | 0.09% | 0.00% | -0.2% | Q4 2021 | |
| $325K | 0.09% | 0.00% | -0.5% | Q3 2025 | |
| $315K | 0.09% | 0.00% | +7.9% | Q4 2024 | |
| $314K | 0.09% | Not reported | -0.4% | Q4 2023 | |
| $299K | 0.08% | 0.00% | +0.4% | Q3 2025 | |
| $284K | 0.08% | 0.00% | +0.9% | Q4 2024 | |
| $275K | 0.08% | 0.00% | -0.6% | Q2 2024 | |
| $262K | 0.07% | Not reported | Not reported | Q4 2021 | |
| $256K | 0.07% | 0.02% | +1.6% | Q1 2023 | |
| Q4 2025Reported Jan 6, 202659 positions | |||||
| $27.3M | 7.96% | Not reported | -0.7% | Q4 2021 | |
| $14M | 4.08% | Not reported | +4.1% | Q4 2021 | |
| $9.07M | 2.64% | 0.01% | -3.3% | Q4 2021 | |
| $6.55M | 1.91% | Not reported | -0.9% | Q1 2022 | |
| $3.59M | 1.04% | 0.00% | +3.6% | Q4 2021 | |
| $3.03M | 0.88% | 0.01% | +14.8% | Q4 2021 | |
| $2.93M | 0.85% | 0.00% | -4.5% | Q4 2021 | |
| $2.07M | 0.60% | 0.00% | +18.7% | Q4 2021 | |
| $1.87M | 0.54% | 0.00% | +15.2% | Q4 2021 | |
| $1.74M | 0.51% | 0.00% | +2.8% | Q3 2023 | |
| $1.27M | 0.37% | 0.00% | -5.5% | Q4 2021 | |
| $1.2M | 0.35% | Not reported | +128.0% | Q4 2023 | |
| $1.17M | 0.34% | 0.00% | +0.1% | Q4 2021 | |
| $1.08M | 0.31% | 0.00% | 0.0% | Q3 2022 | |
| $971K | 0.28% | 0.00% | +28.8% | Q2 2025 | |
| $902K | 0.26% | 0.00% | Not reported | Q4 2021 | |
| $873K | 0.25% | 0.00% | +5.6% | Q4 2021 | |
| $770K | 0.22% | 0.00% | Not reported | Q4 2024 | |
| $758K | 0.22% | 0.14% | +34.2% | Q2 2025 | |
| $731K | 0.21% | 0.00% | +0.5% | Q4 2021 | |
| $695K | 0.20% | Not reported | +7.7% | Q4 2021 | |
| $672K | 0.20% | Not reported | -0.1% | Q1 2022 | |
| $620K | 0.18% | 0.00% | +84.8% | Q1 2022 | |
| $591K | 0.17% | 0.00% | +4.3% | Q4 2021 | |
| $587K | 0.17% | Not reported | -1.5% | Q1 2023 | |
| $580K | 0.17% | 0.00% | +1.1% | Q4 2021 | |
| $531K | 0.15% | 0.00% | +0.2% | Q4 2021 | |
| $518K | 0.15% | 0.02% | +1.5% | Q4 2024 | |
| $500K | 0.15% | Not reported | +3.6% | Q4 2023 | |
| $470K | 0.14% | 0.00% | +11.4% | Q3 2025 | |
| $457K | 0.13% | 0.05% | -1.7% | Q4 2021 | |
| $448K | 0.13% | Not reported | -13.8% | Q4 2021 | |
| $414K | 0.12% | 0.00% | Not reported | Q3 2025 | |
| $403K | 0.12% | 0.00% | -1.0% | Q4 2021 | |
| $344K | 0.10% | Not reported | -0.8% | Q4 2023 | |
| $343K | 0.10% | 0.00% | +0.8% | Q1 2022 | |
| $328K | 0.10% | 0.01% | -37.6% | Q4 2022 | |
| $319K | 0.09% | 0.00% | -5.6% | Q4 2021 | |
| $318K | 0.09% | 0.00% | +0.2% | Q4 2024 | |
| $318K | 0.09% | 0.00% | +6.7% | Q3 2025 | |
| $311K | 0.09% | 0.00% | +5.9% | Q4 2024 | |
| $296K | 0.09% | 0.00% | Not reported | Q4 2021 | |
| $280K | 0.08% | 0.00% | New | Q4 2025 | |
| $268K | 0.08% | Not reported | Not reported | Q4 2022 | |
| $261K | 0.08% | Not reported | -5.2% | Q4 2021 | |
| $256K | 0.07% | 0.00% | -1.3% | Q2 2024 | |
| $256K | 0.07% | 0.00% | New | Q4 2025 | |
| $246K | 0.07% | Not reported | +2.4% | Q4 2021 | |
| $246K | 0.07% | 0.00% | +0.2% | Q4 2024 | |
| $242K | 0.07% | 0.00% | +0.1% | Q4 2024 | |
| Q3 2025Reported Nov 7, 202557 positions | |||||
| $27M | 8.78% | Not reported | -0.6% | Q4 2021 | |
| $13.4M | 4.36% | Not reported | +4.6% | Q4 2021 | |
| $8.39M | 2.72% | 0.02% | -4.0% | Q4 2021 | |
| $6.24M | 2.02% | Not reported | -3.8% | Q1 2022 | |
| $3.8M | 1.23% | 0.00% | +5.9% | Q4 2021 | |
| $2.89M | 0.94% | 0.00% | +15.8% | Q4 2021 | |
| $1.87M | 0.61% | 0.00% | +23.4% | Q4 2021 | |
| $1.72M | 0.56% | 0.01% | +49.9% | Q4 2021 | |
| $1.68M | 0.55% | 0.00% | +9.2% | Q3 2023 | |
| $1.66M | 0.54% | 0.00% | Not reported | Q4 2021 | |
| $1.61M | 0.52% | 0.00% | +78.2% | Q4 2021 | |
| $1.05M | 0.34% | 0.00% | +48.5% | Q3 2022 | |
| $912K | 0.30% | 0.00% | +17.0% | Q4 2021 | |
| $815K | 0.26% | 0.00% | +67.5% | Q2 2025 | |
| $806K | 0.26% | 0.00% | +0.4% | Q4 2021 | |
| $747K | 0.24% | 0.00% | -0.9% | Q4 2021 | |
| $716K | 0.23% | 0.00% | +0.2% | Q4 2021 | |
| $708K | 0.23% | 0.02% | -17.4% | Q4 2024 | |
| $696K | 0.23% | 0.00% | +141.8% | Q4 2024 | |
| $679K | 0.22% | Not reported | +4.1% | Q4 2021 | |
| $659K | 0.21% | 0.00% | +0.5% | Q4 2021 | |
| $644K | 0.21% | 0.00% | -6.4% | Q4 2021 | |
| $602K | 0.20% | Not reported | -3.4% | Q1 2022 | |
| $586K | 0.19% | 0.00% | +0.4% | Q4 2021 | |
| $583K | 0.19% | Not reported | -2.1% | Q1 2023 | |
| $581K | 0.19% | Not reported | -10.3% | Q4 2021 | |
| $548K | 0.18% | 0.10% | +101.0% | Q2 2025 | |
| $530K | 0.17% | Not reported | +1.4% | Q4 2023 | |
| $493K | 0.16% | 0.06% | -6.6% | Q4 2021 | |
| $435K | 0.14% | 0.00% | New | Q3 2025 | |
| $411K | 0.13% | 0.00% | +47.9% | Q4 2021 | |
| $382K | 0.12% | Not reported | +4.3% | Q4 2023 | |
| $382K | 0.12% | 0.01% | -2.7% | Q4 2022 | |
| $379K | 0.12% | 0.00% | New | Q3 2025 | |
| $376K | 0.12% | Not reported | +0.1% | Q4 2023 | |
| $336K | 0.11% | 0.00% | +40.1% | Q4 2021 | |
| $326K | 0.11% | 0.00% | -0.4% | Q1 2022 | |
| $306K | 0.10% | 0.00% | +43.9% | Q1 2022 | |
| $305K | 0.10% | 0.00% | +0.1% | Q4 2024 | |
| $295K | 0.10% | 0.00% | New | Q3 2025 | |
| $282K | 0.09% | 0.00% | New | Q3 2025 | |
| $280K | 0.09% | 0.00% | +0.5% | Q4 2024 | |
| $274K | 0.09% | Not reported | -22.7% | Q4 2021 | |
| $271K | 0.09% | Not reported | 0.0% | Q4 2022 | |
| $262K | 0.09% | 0.00% | Not reported | Q4 2021 | |
| $247K | 0.08% | 0.00% | New | Q3 2025 | |
| $243K | 0.08% | 0.00% | +8.4% | Q4 2024 | |
| $241K | 0.08% | Not reported | -12.2% | Q4 2021 | |
| $236K | 0.08% | 0.00% | +0.9% | Q2 2024 | |
| $236K | 0.08% | 0.00% | New | Q3 2025 | |
Premium opens every quarter this fund has filed